ENG, endoglin, 2022

N. diseases: 371; N. variants: 114
Source: ALL
Disease Score gda Association Type Type Original DB Sentence supporting the association PMID PMID Year
Hereditary hemorrhagic telangiectasia
1.000 Biomarker disease BEFREE Mutant endoglin in hereditary hemorrhagic telangiectasia type 1 is transiently expressed intracellularly and is not a dominant negative. 9366572 1997
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Hereditary haemorrhagic telangiectasia (HHT or Rendu-Osler-Weber syndrome) is an autosomal dominant disorder characterized by localized angiodysplasia due to mutations in endoglin, ALK-1 gene, and a still unidentified locus. 16429404 2006
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Clinical heterogeneity in hereditary haemorrhagic telangiectasia: are pulmonary arteriovenous malformations more common in families linked to endoglin? 8728706 1996
Hereditary hemorrhagic telangiectasia
1.000 Biomarker disease BEFREE Characterization of a mutation in the zona pellucida module of Endoglin that causes Hereditary Hemorrhagic Telangiectasia. 30763665 2019
Hereditary hemorrhagic telangiectasia
1.000 AlteredExpression disease BEFREE Endoglin expression is reduced in normal vessels but still detectable in arteriovenous malformations of patients with hereditary hemorrhagic telangiectasia type 1. 10702408 2000
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE This is the first experimental demonstration that a 5'-UTR mutation can prevent translation of ENG among HHT patients, and further supports the previous notion that haploinsufficiency is the primary mechanism of HHT1. 21967607 2011
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Hereditary Hemorrhagic Telangiectasia (HHT) patients with haploinsufficiency of endoglin (ENG, HHT1) or activin receptor-like kinase 1 (ALK1, HHT2) have a higher incidence of bAVM than the general population. 22571958 2012
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Endoglin and ALK1 mutations are thought to affect endothelial cell metabolism, angiogenesis and vascular remodelling, even if the precise mechanism leading to the HHT lesions is still obscure. 18220803 2007
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Mutations in endoglin and in activin receptor-like kinase 1 among Danish patients with hereditary haemorrhagic telangiectasia. 15521985 2004
Hereditary hemorrhagic telangiectasia
1.000 AlteredExpression disease BEFREE Soluble endoglin regulates expression of angiogenesis-related proteins and induction of arteriovenous malformations in a mouse model of hereditary hemorrhagic telangiectasia. 30108051 2018
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE ENG mutational mosaicism in a family with hereditary hemorrhagic telangiectasia. 29243366 2018
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Somatic Mutations in Vascular Malformations of Hereditary Hemorrhagic Telangiectasia Result in Bi-allelic Loss of ENG or ACVRL1. 31630786 2019
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Familial cases have long been recognised and are usually due to mutations in the bone morphogenetic protein receptor type 2 gene (BMPR2), or, much less commonly, two other members of the transforming growth factor-β superfamily, activin-like kinase-type 1 (ALK1), and endoglin (ENG), which are associated with hereditary hemorrhagic telangiectasia. 23733703 2011
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Hereditary hemorrhagic telangiectasia: ENG and ALK-1 mutations in Dutch patients. 15517393 2005
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Expression analysis of four endoglin missense mutations suggests that haploinsufficiency is the predominant mechanism for hereditary hemorrhagic telangiectasia type 1. 10545596 1999
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Mutations in endoglin result in the vascular defect known as hereditary hemorrhagic telangiectasia (HHT1). 21737454 2011
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Two common endoglin mutations in families with hereditary hemorrhagic telangiectasia in the Netherlands Antilles: evidence for a founder effect. 10982033 2000
Hereditary hemorrhagic telangiectasia
1.000 Biomarker disease BEFREE Endoglin, a TGF-beta binding protein of endothelial cells, is the gene for hereditary haemorrhagic telangiectasia type 1. 7894484 1994
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Thus, our study supports that screening for large rearrangements should be considered to improve the genetic analysis in HHT patients with no apparent mutations in ALK1 and ENG using direct sequencing. 18312453 2008
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Background Hereditary hemorrhagic telangiectasia ( HHT ) is a rare genetic vascular disorder caused by mutations in endoglin ( ENG ), activin receptor-like kinase 1 ( ACVRL 1; ALK 1), or SMAD 4. 30571376 2018
Hereditary hemorrhagic telangiectasia
1.000 Biomarker disease BEFREE A novel ENG mutation causing impaired co-translational processing of endoglin associated with hereditary hemorrhagic telangiectasia. 22385575 2012
Hereditary hemorrhagic telangiectasia
1.000 AlteredExpression disease BEFREE Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes. 15375013 2004
Hereditary hemorrhagic telangiectasia
1.000 Biomarker disease BEFREE Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. 28796572 2017
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Linkage studies established an ORW locus at chromosome 9q3; endoglin was subsequently identified as the ORW1 gene. 8640225 1996
Hereditary hemorrhagic telangiectasia
1.000 GeneticVariation disease BEFREE Mutations in endoglin (ENG) or activin A receptor type II-like 1 (ACVRL1) account for around 90% of HHT patients, 10% of those are large deletions or duplications. 20412114 2010